#consumer health

2 stories

#60 millions de consommateurs #adverse effects #bayer #digestive health #drug safety #drug testing #france #glp-1 #india #multivitamins #obesity drugs #over-the-counter medications

Bayer Targets GLP-1 Side Effect Solutions for India
Bayer plans to launch products addressing GLP-1 drug side effects in India by 2030.
The Economic Times · 1m
Over-the-counter drugs that aren't worth buying
A consumer watchdog tested 100+ over-the-counter medicines and found most are either ineffective or risky.
Psychologies · 1m